SMA Solar (S92) Q3 2025 earnings summary

Executive summary

• Sales increased 7.1% year-over-year to €1,134.7 million for Q1–Q3 2025, driven by Large Scale & Project Solutions, while Home & Business Solutions (HBS) underperformed due to weak demand and competitive pressure.

• EBITDA dropped sharply to €-17 million from €84 million in the prior year period, mainly due to significant one-off effects and impairments in HBS.

• Free cash flow turned positive at €115 million, a substantial improvement from €-220 million in 9M 2024, supported by net working capital reduction and divestments.

• Significant restructuring and transformation program expanded, targeting over €100 million in annual cost savings by 2027.

• Strategic focus is shifting towards core European markets, with workforce reductions in Germany and non-core markets, and expansion in Poland and India.

Financial highlights

• 2025 sales are expected to be well below the previous year's level for the HBS division, while Large Scale & Project Solutions anticipates sales slightly above the high level of the previous year.

• EBITDA and EBIT will be negatively impacted by lower sales and one-off restructuring costs, with EBITDA margin dropping to -1.5% from 7.9% year-over-year.

• Net income for 9M 2025 was €-145 million, down from €35 million in 9M 2024.

• One-off charges totaling €215–265 million are expected, with €45 million recognized in Q2 and €159 million in Q3.

• Order backlog decreased to €1,282 million from €1,438 million year-over-year, with Large Scale order intake recovering in Q3.

Outlook and guidance

• 2025 sales guidance is €1,450–1,500 million, with EBITDA expected between minus €80 million and minus €30 million due to one-time effects and restructuring.

• Management expects negative one-time effects totaling €170–220 million, including inventory devaluations, impairments, and restructuring accruals.

• Further restructuring provisions will be added in Q4, mainly for severance payments estimated at €30–40 million.

• No expectation of breakeven for HBS in 2025; breakeven post-restructuring requires at least €300 million in sales.

• Large Scale order intake in Q4 expected to be €300–400 million, lower than Q3 but still solid.